What is the recommendation of the Work Group for patients aged Z50 years?
In the judgment of the Work Group, these data warrant a strong recommendation that ezetimibe monotherapy is not recommended for patients with or without CKD, and that knowledge of LDL-C is not required to gauge average coronary risk in this population.